Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-18-001245

Options or other derivatives

  • Chief Scientific Officer acquired 47,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Kidron Miriam Chief Scientific Officer 2018-01-31 Grant or award · Stock Option (right to buy) +47,000 47,000 D
Loading xslF345X03/f4013118kidronmiriam_oramed.xml…